Detalles de la búsqueda
1.
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1.
Gene Ther
; 28(3-4): 186-198, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33149278
2.
A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer.
Br J Cancer
; 124(4): 713-720, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191408
3.
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.
BMC Cancer
; 21(1): 802, 2021 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253172
4.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31587882
5.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Lancet Oncol
; 19(4): 521-536, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545095
6.
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.
N Engl J Med
; 372(18): 1689-99, 2015 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25923549
7.
The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.
Br J Clin Pharmacol
; 84(6): 1156-1169, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381826
8.
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
Br J Cancer
; 117(6): 757-766, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28772281
9.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Lancet
; 387(10027): 1540-1550, 2016 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712084
10.
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
Cancer
; 122(19): 3024-31, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315356
11.
Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy.
Pharmacogenet Genomics
; 26(3): 116-25, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26641474
12.
Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.
Apoptosis
; 21(3): 351-64, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26677013
13.
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
BMC Cancer
; 16: 224, 2016 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26979333
14.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Lancet
; 384(9944): 665-73, 2014 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933332
15.
Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
Cancer
; 120(14): 2090-8, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24737599
16.
Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus.
Biochem Biophys Res Commun
; 453(3): 480-5, 2014 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25280999
17.
Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer.
Tumour Biol
; 35(12): 12173-80, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25179838
18.
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
Cancer Med
; 13(7): e7174, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38622869
19.
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201.
Lung Cancer
; 190: 107509, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38432025
20.
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
Cancer Res Treat
; 56(1): 48-60, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402411